Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
J Pediatr ; 249: 59-66.e1, 2022 10.
Artículo en Inglés | MEDLINE | ID: mdl-35772508

RESUMEN

OBJECTIVE: To assess whether the severity of cases of spina bifida changed after the institution of mandatory folic acid fortification in the US. STUDY DESIGN: Six active population-based birth defects programs provided data on cases of spina bifida for 1992-1996 (prefortification period) and 1999-2016 (postfortification period). The programs contributed varying years of data. Case information included both a medical record verbatim text description of the spina bifida diagnosis and spina bifida codes (International Classification of Diseases, Clinical Modification, or a modified birth defects surveillance coding system). Comparing the prefortification and postfortification periods, aORs for case severity (upper-level lesions [cervical, thoracic] vs lower-level lesions [lumbar, sacral]) and prevalence ratios (PRs) were estimated. RESULTS: A total of 2593 cases of spina bifida (out of 7 816 062 live births) met the inclusion criteria, including 573 cases from the prefortification period and 2020 cases from the postfortification period. Case severity decreased by 70% (aOR, 0.30; 95% CI, 0.26-0.35) between the fortification periods. The decrease was most pronounced for non-Hispanic White mothers. Overall spina bifida prevalence declined by 23% (PR, 0.77; 95% CI, 0.71-0.85), with similar reductions seen across the early, mid, and recent postfortification periods. A statistically significant decrease in upper-level lesions occurred in the postfortification period compared with the prefortification period (PR, 0.28; 95% CI, 0.22-0.34), whereas the prevalence of lower-level lesions remained relatively similar (PR, 0.94; 95% CI, 0.84-1.05). CONCLUSIONS: The severity of spina bifida cases decreased after mandatory folic acid fortification in the US. Further examination is warranted to better understand the potential effect of folic acid on spina bifida severity.


Asunto(s)
Ácido Fólico , Disrafia Espinal , Femenino , Ácido Fólico/uso terapéutico , Alimentos Fortificados , Humanos , Nacimiento Vivo , Embarazo , Prevalencia , Disrafia Espinal/epidemiología , Disrafia Espinal/prevención & control
2.
Birth Defects Res ; 114(5-6): 184-196, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-35098705

RESUMEN

BACKGROUND: Neural tube defects (NTDs) encompass a variety of distinct types. We assessed if the preventive effect of folic acid (FA) varied by NTD type and infant sex. METHODS: We examined all pregnancies with NTD status confirmation from a pregnancy-monitoring system in selected locations in northern and southern regions of China between 1993 and 1996. Women who took 400 µg of FA daily during 42 days after last menstrual period were considered FA users. We analyzed NTD prevalence by FA use status, NTD type, geographic region, and infant sex. RESULTS: Among 626,042 pregnancies, 700 were affected by an NTD. Among FA nonusers, 65 pregnancies (8.8 per 10,000) in the north and 51 pregnancies (1.2 per 10,000) in the south were affected by one of the two rare NTDs, that is, craniorachischisis, iniencephaly. FA use prevented occurrence of these two rare NTDs and reduced the prevalence of spina bifida (SB) by 78% (from 17.9 to 3.9 per 10,000) in the north and 51% (from 2.4 to 1.2 per 10,000) in the south. Among FA users, SB prevalence, including SB with high lesion level, was significantly reduced in both geographic regions. FA use reduced prevalence of anencephaly and encephalocele by 85% and 50%, respectively in the north, while it did not reduce the prevalence of these two NTDs in the south. There was a greater reduction in NTD prevalence in female than in male infants and fetuses. CONCLUSIONS: This is the first study to show that FA prevents the entire spectrum of NTD types.


Asunto(s)
Anencefalia , Defectos del Tubo Neural , Disrafia Espinal , Anencefalia/epidemiología , Anencefalia/prevención & control , China/epidemiología , Suplementos Dietéticos , Femenino , Ácido Fólico , Humanos , Masculino , Defectos del Tubo Neural/epidemiología , Defectos del Tubo Neural/prevención & control , Embarazo , Disrafia Espinal/epidemiología , Disrafia Espinal/prevención & control
3.
Birth Defects Res ; 110(12): 994-1000, 2018 07 17.
Artículo en Inglés | MEDLINE | ID: mdl-29762915

RESUMEN

INTRODUCTION: We examined the association of biliary atresia with maternal dietary intake, using National Birth Defects Prevention Study (NBDPS) data from 152 cases and 11,112 nonmalformed controls born 1997-2011. METHODS: NBDPS is a multisite, population-based case-control study. Exposure data were from maternal telephone interviews, which included a food frequency questionnaire. Odds ratios (OR) and 95% confidence intervals (CI) were generated from logistic regression models that included nutritional factors as continuous variables and were adjusted for energy intake only or energy intake plus covariates (maternal race-ethnicity, education, age, prepregnancy body mass index, vitamin/mineral supplement intake, conception during summer). Models included a quadratic term for the nutrient if p < 0.10. ORs reflect odds of having biliary atresia for nutrient values at the 75th compared to 25th percentile values of each nutrient, based on distributions among controls. RESULTS: ORs for which the 95% CI excluded 1.00 were energy-adjusted ORs for calcium (0.63), protein (0.65), riboflavin (0.71), and diet quality index (0.69), and fully adjusted ORs for calcium (0.68) and vitamin E (0.72). ORs that were fully adjusted for covariates tended to be closer to 1.0 than ORs adjusted only for energy intake. ORs for the other studied nutrients had 95% CIs that included 1.00. CONCLUSIONS: NBDPS is the first study to include detailed information on maternal dietary intake and risk of biliary atresia. Our results suggest reduced risks associated with some nutrients, which may provide etiologic clues but should be interpreted with caution given the small number of cases and novelty of the investigation.


Asunto(s)
Atresia Biliar/etiología , Dieta/efectos adversos , Efectos Tardíos de la Exposición Prenatal/etiología , Adulto , Femenino , Humanos , Recién Nacido , Oportunidad Relativa , Embarazo , Factores de Riesgo
4.
MMWR Morb Mortal Wkly Rep ; 64(1): 6-9, 2015 Jan 16.
Artículo en Inglés | MEDLINE | ID: mdl-25590679

RESUMEN

Neural tube defects (NTDs) include anomalies of the brain (anencephaly and encephalocele) and spine (spina bifida). Even with ongoing mandatory folic acid fortification of enriched cereal grain products, the U.S. Preventive Services Task Force recommends that women of childbearing potential consume a daily supplement containing 400 µg-800 µg of folic acid. Women with a prior NTD-affected pregnancy have an increased risk for having another NTD-affected pregnancy, and if they are planning another pregnancy, the recommendation is that they consume high-dosage folic acid supplements (4.0 mg/day) beginning ≥4 weeks before conception and continuing through the first 12 weeks of pregnancy. To learn whether folic acid supplementation (from multivitamins or single- ingredient supplements) was commonly used during pregnancy by women with a previous NTD-affected pregnancy, supplement use was assessed among a convenience sample of women with a previous NTD-affected pregnancy who participated in the National Birth Defects Prevention Study (NBDPS), a case-control study of major birth defects in the United States. Characteristics of women who previously had an NTD-affected pregnancy and whose index pregnancy (pregnancy included in NBDPS) was either affected by an NTD (N = 17) (i.e., recurrence-cases) or resulted in a live-born infant without a major birth defect (N = 10) (i.e., recurrence-controls) were assessed. Taking a supplement that included folic acid was more common among recurrence-control mothers (80%) than recurrence-case mothers (35%). The recommendation that women should take folic acid supplements just before and during early pregnancy is not being followed by many women and offers an opportunity for NTD prevention, especially among women who are at a higher risk because they have had a previous pregnancy affected by an NTD.


Asunto(s)
Suplementos Dietéticos/estadística & datos numéricos , Ácido Fólico/administración & dosificación , Conocimientos, Actitudes y Práctica en Salud , Defectos del Tubo Neural/prevención & control , Mujeres Embarazadas/psicología , Negro o Afroamericano/psicología , Negro o Afroamericano/estadística & datos numéricos , Estudios de Casos y Controles , Femenino , Hispánicos o Latinos/psicología , Hispánicos o Latinos/estadística & datos numéricos , Humanos , Defectos del Tubo Neural/epidemiología , Obesidad/epidemiología , Embarazo , Mujeres Embarazadas/etnología , Recurrencia , Medición de Riesgo , Factores de Riesgo , Estados Unidos/epidemiología , Población Blanca/psicología , Población Blanca/estadística & datos numéricos
5.
Glob Adv Health Med ; 2(3): 87-9, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-24278844

RESUMEN

Integrative health coaching (IHC) offers significant health improvement in biometric measures without pharmaceuticals. In this case of newly diagnosed impaired glucose tolerance (IGT) with obesity, IHC used the patient's strengths to reverse IGT, prevent frank diabetes, and reduce weight by 40 lbs or 21% of her original weight. This intervention included a client self-assessment and 14 in-person health coaching sessions over 11 months. IHC provides a framework to accomplish short-term goals and identify and overcome barriers while drawing on the strengths and aims of the individual.


La formación sanitaria integral (IHC) consigue una mejoría sanitaria significativa en las mediciones biométricas sin productos farmacéuticos. En este caso recién diagnosticado de intolerancia a la glucosa (IG) con obesidad, la IHC utilizó los puntos fuertes de la paciente para invertir la IG, evitar una diabetes manifiesta y reducir el peso en 18 kg o en un 21 % de su peso original. La intervención incluyó una autoevaluación de la cliente y 14 sesiones presenciales de formación sanitaria a lo largo de 11 meses. La IHC proporciona un marco para conseguir objetivos a corto plazo, así como para detectar y superar obstáculos, al mismo tiempo que se aprovechan los puntos fuertes y los objetivos del individuo.

6.
Am J Obstet Gynecol ; 206(3): 218.e1-13, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22284962

RESUMEN

OBJECTIVE: The purpose of this study was to examine the risk of birth defects in relation to diabetes mellitus and the lack of use of periconceptional vitamins or supplements that contain folic acid. STUDY DESIGN: The National Birth Defects Prevention Study (1997-2004) is a multicenter, population-based case-control study of birth defects (14,721 cases and 5437 control infants). Cases were categorized into 18 types of heart defects and 26 noncardiac birth defects. We estimated odds ratios for independent and joint effects of preexisting diabetes mellitus and a lack of periconceptional use of vitamins or supplements that contain folic acid. RESULTS: The pattern of odds ratios suggested an increased risk of defects that are associated with diabetes mellitus in the absence vs the presence of the periconceptional use of vitamins or supplements that contain folic acid. CONCLUSION: The lack of periconceptional use of vitamins or supplements that contain folic acid may be associated with an excess risk for birth defects due to diabetes mellitus.


Asunto(s)
Anencefalia/prevención & control , Anomalías Congénitas/prevención & control , Suplementos Dietéticos , Ácido Fólico/uso terapéutico , Complicaciones del Embarazo/prevención & control , Embarazo en Diabéticas/tratamiento farmacológico , Anencefalia/tratamiento farmacológico , Anencefalia/epidemiología , Estudios de Casos y Controles , Anomalías Congénitas/tratamiento farmacológico , Anomalías Congénitas/epidemiología , Diabetes Mellitus/tratamiento farmacológico , Diabetes Mellitus/epidemiología , Femenino , Humanos , Lactante , Embarazo , Complicaciones del Embarazo/tratamiento farmacológico , Embarazo en Diabéticas/epidemiología
7.
Am J Obstet Gynecol ; 204(5): 404.e1-404.e10, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21396620

RESUMEN

OBJECTIVE: Gastroschisis is increasing in many countries, especially among young women. Because young women may have inadequate nutrition, we assessed the relationship between individual nutrients and the risk for gastroschisis. STUDY DESIGN: We analyzed data from the National Birth Defects Prevention Study, a population-based case-control study. Cases were ascertained from 10 birth defect surveillance systems. Controls were randomly selected from birth certificates or hospital records. Nutrient intake was estimated for the year prior to conception from maternal interviews based on a 58-item food frequency questionnaire and cereal consumption reported. A total of 694 cases and 6157 controls were available for analysis. RESULTS: Reported intake of individual nutrients did not substantially affect the risk for gastroschisis. Stratification by maternal age, preconception body mass index, folic acid-containing supplements, or energy intake (kilocalories) did not alter risk estimates. CONCLUSION: This study does not support an increased risk for gastroschisis with decreasing tertiles of individual nutrients.


Asunto(s)
Gastrosquisis/etiología , Fenómenos Fisiologicos Nutricionales Maternos/fisiología , Adolescente , Adulto , Índice de Masa Corporal , Estudios de Casos y Controles , Femenino , Gastrosquisis/epidemiología , Humanos , Edad Materna , Embarazo , Prevalencia , Riesgo , Factores de Riesgo , Encuestas y Cuestionarios
8.
Am J Prev Med ; 35(1): 47-54, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18541176

RESUMEN

BACKGROUND: Osteoporosis is a major public health concern and has been associated with a family history positive for the condition. However, data on the behaviors of individuals with such a family history are scarce. The objectives of this study were to assess the relationship between the prevalence of reported physician-diagnosed osteoporosis and family history in a representative sample of U.S. women, examine whether osteoporosis risk factors account for this relationship, and evaluate the likelihood that women at high risk of osteoporosis due to family history report preventive behaviors. METHODS: The prevalence of reported osteoporosis was estimated in 8073 women aged>or=20 years in the National Health and Nutrition Examination Survey, 1999-2004. Information on osteoporosis in first-degree relatives and grandparents was obtained during interviews. RESULTS: The prevalence of osteoporosis in participants was 7.94%. In 19.8% of them, a positive family history was reported and was significantly and independently associated with osteoporosis (AOR 2.35, 95% CI=1.87, 2.96). This association was stronger when two or more relatives were affected (AOR 8.48, 95% CI=4.50, 15.99). After stratification by age, the association was observed only in women aged>or=35 years. Women with a family history of osteoporosis were more likely than those with none to report preventive behavior, such as taking supplements of calcium, vitamin D, or both; physical activity; and estrogen use. CONCLUSIONS: These findings indicate that family history is a significant, independent risk factor for osteoporosis in U.S. women aged>or=35 years. Further studies are warranted to evaluate family history as a convenient and inexpensive tool for identifying women at risk of osteoporosis and for promoting the adoption of preventive behaviors.


Asunto(s)
Osteoporosis/epidemiología , Adulto , Femenino , Promoción de la Salud , Humanos , Oportunidad Relativa , Osteoporosis/genética , Osteoporosis/prevención & control , Factores de Riesgo , Estados Unidos/epidemiología
9.
Am J Med Genet A ; 143A(20): 2397-405, 2007 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-17853468

RESUMEN

Although it has been well established that periconceptional use of multivitamins containing folic acid (FA) reduces the risk for neural tube defects, two recent U.S. studies have shown an increased risk for multiple congenital anomalies (MCAs) associated with periconceptional use of vitamins containing FA. This study assessed the association between the periconceptional use of vitamins containing FA and MCAs in a third U.S. population. Mothers of infants with MCAs and a random sample of live births (control infants) born in Iowa during 1993-1995 were eligible to participate in the Birth Defects Risk Factor Surveillance case-control study. During a telephone interview, participants reported on exposure to FA through vitamins, cereal, and food supplements. There was no association between taking vitamins containing FA during the periconceptional period (3 months before conception through the first trimester) and MCAs in the crude estimates or after adjusting for maternal race or ethnicity, education, gravidity, smoking, or alcohol use in the first trimester, or body mass index prior to pregnancy [adjusted odds ratio (aOR)=1.12, 95% confidence interval (CI) 0.75-1.69]. There was also no association between vitamin exposure beginning in the first trimester and MCAs outcome (aOR=1.05, 95% CI 0.59-1.87). In contrast to the two recently published reports, there was no association between periconceptional vitamin exposure and MCAs in the Iowa population.


Asunto(s)
Anomalías Múltiples/epidemiología , Ácido Fólico/efectos adversos , Complejo Vitamínico B/efectos adversos , Anomalías Múltiples/prevención & control , Adulto , Estudios de Casos y Controles , Femenino , Ácido Fólico/uso terapéutico , Humanos , Recién Nacido , Masculino , Atención Preconceptiva , Embarazo , Factores de Riesgo , Complejo Vitamínico B/uso terapéutico
10.
Am J Med Genet A ; 136(1): 1-7, 2005 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-15937944

RESUMEN

The purpose of this case-control study was to determine whether multivitamin use is associated with the occurrence of multiple congenital anomalies (MCA). MCA case-infants were infants with two or more major birth defects affecting at least two different organ systems, with no recognized chromosome abnormality or single gene disorder. Control-infants were a random sample of live births with no major birth defects from the same population (metropolitan Atlanta) and time period (1993-1997) as the case-infants. Exposure to multivitamins, cereals, and supplements was ascertained from a maternal telephone interview and classified based on folic acid content. We compared women who used multivitamins three or more times per week with women who were not exposed to vitamins/cereals/supplements during the periconceptional period (3 months before pregnancy through the first trimester), adjusting for maternal age, education, race/ethnicity, first degree family history of a major birth defect, pre-pregnancy maternal body mass index, gravidity, and first trimester alcohol use and cigarette smoking. Periconceptional multivitamin use was associated with MCA among all infants (adjusted odds ratio [aOR]=2.4, 95% confidence interval [CI] 0.9-6.7), and especially when analysis was limited to those with no family history of major defects (aOR=4.0, 95% CI 1.3-12.8). MCA-infants with urinary obstructive defects were more common among multivitamin-exposed infants than among unexposed infants, but this defect did not occur within a consistent pattern of defects. While these findings provide some support for one previous study, the interpretation remains unclear given the proven protective effect of multivitamins containing folic acid on isolated neural tube defects and possibly other types of defects.


Asunto(s)
Anomalías Inducidas por Medicamentos/etiología , Anomalías Múltiples/inducido químicamente , Vitaminas/administración & dosificación , Anomalías Múltiples/patología , Estudios de Casos y Controles , Suplementos Dietéticos , Femenino , Ácido Fólico/administración & dosificación , Ácido Fólico/efectos adversos , Georgia , Humanos , Recién Nacido , Edad Materna , Oportunidad Relativa , Atención Preconceptiva , Embarazo , Primer Trimestre del Embarazo , Medición de Riesgo/métodos , Medición de Riesgo/estadística & datos numéricos , Factores de Riesgo , Obstrucción Uretral/inducido químicamente , Vitaminas/efectos adversos
11.
J Neurosci ; 24(43): 9541-52, 2004 Oct 27.
Artículo en Inglés | MEDLINE | ID: mdl-15509741

RESUMEN

Normal striatal function is dependent on the availability of synaptic dopamine to modulate neurotransmission. Within the striatum, excitatory inputs from cortical glutamatergic neurons and modulatory inputs from midbrain dopamine neurons converge onto dendritic spines of medium spiny neurons. In addition to dopamine receptors on medium spiny neurons, D2 receptors are also present on corticostriatal terminals, where they act to dampen striatal excitation. To determine the effect of dopamine depletion on corticostriatal activity, we used the styryl dye FM1-43 in combination with multiphoton confocal microscopy in slice preparations from dopamine-deficient (DD) and reserpine-treated mice. The activity-dependent release of FM1-43 out of corticostriatal terminals allows a measure of kinetics quantified by the halftime decay of fluorescence intensity. In DD, reserpine-treated, and control mice, exposure to the D2-like receptor agonist quinpirole revealed modulation of corticostriatal kinetics with depression of FM1-43 destaining. In DD and reserpine-treated mice, quinpirole decreased destaining to a greater extent, and at a lower dose, consistent with hypersensitive corticostriatal D2 receptors. Compared with controls, slices from DD mice did not react to amphetamine or to cocaine with dopamine-releasing striatal stimulation unless the animals were pretreated with l-3,4-dihydroxyphenylalanine (l-dopa). Electron microscopy and immunogold labeling for glutamate terminals within the striatum demonstrated that the observed differences in kinetics of corticostriatal terminals in DD mice were not attributable to aberrant cytoarchitecture or glutamate density. Microdialysis revealed that basal extracellular striatal glutamate was normal in DD mice. These data indicate that dopamine deficiency results in morphologically normal corticostriatal terminals with hypersensitive D2 receptors.


Asunto(s)
Cuerpo Estriado/fisiología , Dopamina/fisiología , Corteza Motora/fisiología , Terminales Presinápticos/fisiología , Animales , Dopamina/deficiencia , Dopaminérgicos/farmacología , Exocitosis/fisiología , Colorantes Fluorescentes , Ácido Glutámico/metabolismo , Levodopa/farmacología , Ratones , Ratones Noqueados , Microdiálisis , Vías Nerviosas/fisiología , Compuestos de Piridinio , Compuestos de Amonio Cuaternario , Quinpirol/farmacología , Receptores de Dopamina D2/agonistas , Receptores de Dopamina D2/fisiología , Reserpina/farmacología , Tirosina 3-Monooxigenasa/genética
12.
Paediatr Perinat Epidemiol ; 17(3): 287-93, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12839541

RESUMEN

We describe a unique birth defects surveillance system in the People's Republic of China. The system was instituted in March 1992 as a component of an evaluation of the effectiveness of a public health campaign using periconceptional folic acid supplementation to prevent neural tube defects, and currently surveys birth cohorts of approximately 150 000 infants per year. Local health care providers collect information in the form of detailed written descriptions and photographs of affected infants. The system allows for detection of birth defects at the local level with later definitive classification and coding; however, information is limited to structural anomalies that are visible on physical examination. This birth defects surveillance system provides an extensive database of infants with major and minor external structural anomalies, including the unique feature of a photographic record for most cases. These data can be used for aetiological studies, descriptive epidemiology and identification of unusual trends.


Asunto(s)
Anomalías Congénitas/epidemiología , Vigilancia de la Población/métodos , China/epidemiología , Recolección de Datos , Interpretación Estadística de Datos , Humanos , Recién Nacido , Fotograbar , Control de Calidad , Sistema de Registros/normas
13.
Gerontologist ; 42(3): 406-15, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12040144

RESUMEN

PURPOSE: A community and faith-based intervention with elderly persons and their adult children involving religious, medical, and academic communities is described. DESIGN AND METHODS: Lifestyle changes and individual and corporate forms of spirituality were affirmed using an expanded Rowe and Kahn model of successful aging. Faculty from academic, medical, state, and religious institutions presented a variety of workshops at a multichurch-sponsored conference that hosted over 500 seniors. RESULTS: Postconference surveys suggested extremely favorable satisfaction rates across all groups represented. The African American religious community provided critical leadership in achieving an excellent African American participation rate. IMPLICATIONS: The model described has the capacity to generate collaborations across denominational, racial, and class barriers, and has the potential of helping to unify the religious community around the important task of promoting successful aging.


Asunto(s)
Envejecimiento , Promoción de la Salud , Espiritualidad , Negro o Afroamericano , Anciano , Humanos , Relaciones Interprofesionales , Modelos Organizacionales , Estados Unidos , Población Blanca
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA